After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
New Delhi: Prime Minister Narendra Modi will visit Kolkata on January 23 to address the 'Parakram
There is a lot of movement in Varanasi of Uttar Pradesh these days. The survey of the Archaeologi
In the 35th match of IPL 2023, Gujarat Titans will clash with Mumbai Indians. In their last match
This Samsung laptop will work for both tablet and laptop, will be available on Amazon from March 18
Samsung Laptop On Amazon: From March 18, you can book Samsung's premium laptop on Amazon. The scr
Lalu Prasad Yadav's condition worrisome, Delhi AIIMS will be shifted from Rims of Ranchi
New Delhi: The condition of RJD chief Lalu Prasad, who is serving a jail sentence in the fodder s
Demonstrations took place in many places in Afghanistan on Wednesday following the Taliban's orde
Indian wicket-keeper batsman Rishabh Pant did not find a place in the playing XI of the first T20
Pakistan's security forces have killed 11 terrorists including 2 suicide bombers during the searc
Amidst the stranglehold of the security forces in Kashmir and the dwindling support of common Kas
NIOS Board Exams 2022: NIOS released date sheet, 10th-12th examinations will start from April 6
NIOS Board Class 10-12th Theory Exams 2022: The National Institute of Open Schooling (NIOS) has r
